Research Founding
Microgrant BOB-661-1321/2023 – IV.3.1 Internal grants of the University of Warsaw for the employees’ research potential increase
Engineering substrate-based inhibitors of Plasmodium SUB1, a potential target for Malaria treatment
This project has received fundingfrom the European Union’s Horizon 2020 research and innovation programme under the Marie SkÅ‚odowska-Curie grant agreement No 898512
06/2020-05/2022
Microgrant BOB-661-9/20 – a support of scientific potential from the central funds of University of Warsaw
Investigation of the effect of thiol group and urea bond on the peptidomimetics' affinity to receptors associated with angiogenesis and enzymatic stability
National Science Centre, Poland, NCN 2017/27/N/NZ7/02473
08/2018-09/2020
Optimisation of ELISA-like test for fluorescein labelled molecules and investigation of the ability of peptidic ligands to bind to human NRP-1 on cells and to cross cell membrane as ligand-receptor complex
French Government scholarship (Bourse du Gouvernement Français)
host: Dr Yves Lepelletier, Institut Imagine site Necker-Enfants malades, Inserm U1163/CNRS ERL 8254, Paris, France
02/2020
Investigation of potentially anti-angiogenic peptidomimetics able to inhibit NRP-1/VEGF-A165 binding using modified ELISA-like platform
STSM funded by Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) COST Action nr: CA15135, supported by the EU Framework Programme Horizon 2020;
host: Dr Yves Lepelletier, Institut Imagine site Necker-Enfants malades, Inserm U1163/CNRS ERL 8254, Paris, France
11/09-14/10/2017
Microgrant BOB-661-203/17 – a support of scientific potential from the central funds of University of Warsaw